期刊文献+

糖尿病性脑梗死患者血清脂蛋白(a)与C反应蛋白水平的比较 被引量:1

暂未订购
导出
摘要 血清脂蛋白(a)作为动脉粥样硬化的危险因素正日益受到人们的重视。有大量的研究表明,动脉粥样硬化斑块不是简单的脂质沉积,而是全身动脉粥样硬化斑块的一种慢性炎性反应,血清C反应蛋白(CRP)是一项敏感的炎性反应性指标。近年的研究揭示CRP与糖尿病及其大血管并发症有关。2型糖尿病时,胰岛素抵抗伴随的脂代谢和糖代谢异常可促进动脉粥样硬化的形成。
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2008年第12期947-947,共1页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
  • 相关文献

参考文献3

二级参考文献20

  • 1宁光,杨军,杨义生,张翼飞,顾卫琼,洪洁,李小英,陈名道,许曼音,陈家伦.脂肪细胞因子的临床和基础研究[J].国外医学(内分泌学分册),2005,25(3):158-160. 被引量:42
  • 2袁国跃,周丽斌,唐金凤,杨颖,顾卫琼,李凤英,洪洁,顾燕云,徐敏,杜鹏飞,李小英,宁光,陈名道.糖耐量受损和2型糖尿病患者血清C反应蛋白与胰岛素敏感指数、脂联素的关系[J].中华内分泌代谢杂志,2005,21(6):507-510. 被引量:50
  • 3陈冯梅,郭志荣,胡晓抒,武鸣,姚才良,周惠,康国栋,刘仕俊.代谢综合征与血脂异常及超敏C反应蛋白水平的关系[J].中华内分泌代谢杂志,2007,23(1):24-25. 被引量:11
  • 4曾芙蓉,都健,崔丽娟.不同糖耐量状态者血清SICAM-1和SVCAM-1水平与炎症相关性研究[J].中华内分泌代谢杂志,2007,23(1):57-59. 被引量:11
  • 5Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes : the atherosclerosis risk in communities study. Diabetes, 2003,52:1799-1805.
  • 6Freeman D J, Norrie J, Caslake M J, et al. C-reactiye protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 2002,51 : 1596- 1600.
  • 7Esposito K, Pontilloa A, Ciotola M, et al. Weight loss reduces interleukin-18 level in obese women. J Clin Endocrinol Metab, 2002, 87:3864-3866.
  • 8Escobar-Morreale HF, Botella-Carretero JI, Villuendas G, et al. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J Clin Endocrinol Metab, 2004,89:806-811.
  • 9Sacco RL,Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for heahhcare professionals from A merican Heart Association/American Stroke Association Council on stroke:co-sponsored by the Council of Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke, 2006, 37:577-617.
  • 10Schrader J, Luders S, Kulschewski A, et al. Morbidity and mortality after stroke. Eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES). Stroke, 2005, 36:1218-1226.

共引文献26

同被引文献9

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部